Odyssean »

Gladstone Commercial Corporation shares owned by Odyssean

Quarter-by-quarter ownership of Gladstone Commercial Corporation (GOOD) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Gladstone Commercial Corporation

Tip: Access up to 7 years of quarterly data

All positions including Gladstone Commercial Corporation held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gladstone Commercial Corporation by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $258k 21k 12.30

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Gladstone Commercial Corporation

BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Invesco
Renaissance Technologies
Charles Schwab Investment Management
Dimensional Fund Advisors
Qube Research & Technologies
Goldman Sachs Group
Northern Trust
AQR Capital Management
Morgan Stanley
Vanguard Fiduciary Trust

View all funds holding Gladstone Commercial Corporation